Neupogen XL Trademark Details
Word Mark | Neupogen Xl |
---|---|
Status | Dead 606 — Abandoned - No Statement of Use Filed |
Serial Number | 77014795 |
---|---|
Status Date | Monday, May 24, 2010 |
Filing Date | Monday, May 24, 2010 |
Attorney | Mark I. Feldman, Christina L. Martini |
Correspondent
Mark I. Feldman, Christina L. Martini
DLA PIPER US LLP
P.O. Box 64807
Chicago IL 60664-0807
DLA PIPER US LLP
P.O. Box 64807
Chicago IL 60664-0807
Case File Statements
Disclaimer with Predetermined Text | Xl |
---|---|
Goods & Services | Pharmaceutical preparations for stimulating white blood cell production |
Classifications
International Class Codes |
005
|
---|---|
U.S. Class Codes | 006, 018, 044, 046, 051, 052 |
Status | 6 — Active |
Status Date | Tuesday, October 10, 2006 |
Primary Code | 005 |
Trademark Timeline
-
Oct 05 2006Trademark application filed with USPTO
-
Oct 10 2006New Application Entered In Tram
-
Nov 03 2006Assigned To Examiner
-
Nov 08 2006Examiners Amendment E-Mailed
-
Nov 08 2006Examiners Amendment -Written
-
Nov 09 2006Examiner's Amendment Entered
-
Nov 18 2006Approved For Pub - Principal Register
-
Dec 06 2006Law Office Publication Review Completed
-
Dec 06 2006Assigned To Lie
-
Jan 10 2007Notice of Publication
-
Jan 30 2007Published For Opposition
-
Apr 24 2007Noa Mailed - Sou Required From Applicant
-
Sep 11 2007Extension 1 Filed
-
Sep 11 2007Teas Extension Received
-
Sep 24 2007Extension 1 Granted
-
Mar 31 2008Extension 2 Filed
-
Mar 31 2008Teas Extension Received
-
Apr 17 2008Extension 2 Granted
-
Sep 15 2008Extension 3 Filed
-
Sep 15 2008Teas Extension Received
-
Sep 18 2008Extension 3 Granted
-
Sep 18 2008Case Assigned To Intent To Use Paralegal
-
Mar 23 2009Extension 4 Filed
-
Mar 23 2009Teas Extension Received
-
Apr 06 2009Extension 4 Granted
-
Apr 06 2009Case Assigned To Intent To Use Paralegal
-
Sep 24 2009Extension 5 Filed
-
Sep 24 2009Teas Extension Received
-
Sep 28 2009Extension 5 Granted
-
May 24 2010Abandonment Notice Mailed - No Use Statement Filed
-
May 24 2010Abandonment - No Use Statement Filed